Mixtures for stimulating glucose up-take
AssigneeLoders Croklaan USA LLC
InventorsAnna Louise Brown, Frederick William Cain, Ingrid Celestina Mohede, Preyesh Parmar, Julia Sarah Rogers, Ulrike Schmid
Life of this patent
Estimating the term…
Loading patent…
AssigneeLoders Croklaan USA LLC
InventorsAnna Louise Brown, Frederick William Cain, Ingrid Celestina Mohede, Preyesh Parmar, Julia Sarah Rogers, Ulrike Schmid
Estimating the term…
Our invention concerns a mixture of CLA glycerides, and/or CLA-fatty acids and or CLA-alkyl esters and another component, wherein the other component (=component A) is selected for its capacity to alleviate problems related to insulin resistance in mammals, using CLA rich diets and/or foods and/or food supplements using an appropriate in vitro test so that in at least one step of the in vitro test, as described in the text, an improvement in test results is obtained of at least 4% by the blend of the CLA derivative and component A when compared to the CLA derivative only. The inventon further concerns CLA rich dietic food, food supplements and foods containing the combination of CLA and component A as defined, while also the use of this combination for achieving an alleviation of insulin resistance is part of the invention.
A mixture of at least one CLA component selected from the group consisting of CLA glycerides, CLA-fatty acids and CLA-alkyl esters, and another one or more components A, wherein said CLA component is such that it can reduce insulin stimulated glucose uptake by adipocytes and wherein component A is selected for its capacity to stimulate glucose up-take in adipocytes from mammals, using an appropriate in vitro glucose up-take assay whereby the glucose up-take stimulation is at least 4% better by use of the mixture of the CLA component and component A when compared to the use of the CLA component only.
A CLA rich diet food wherein the diet food comprises a food component, a component A, capable of stimulating glucose up-take in adipocytes from mammals and wherein component A is present in amounts corresponding with a daily intake of 1 mg to 10 grams of component A per day.
Dependencies are inferred from the claim text.